Cortechs.ai | LesionQuant for assessment of MRI in MS
Contact

LesionQuant for assessment of MRI in MS

LesionQuant for assessment of MRI in MS —a promising supplement to the visual scan inspection

Quantitative measurements of lesion volume, lesion count, distribution of lesions, and brain atrophy have a potentially significant value for evaluating disease progression. We hypothesize that utilizing software designed for evaluating MRI data in MS will provide more accurate and detailed analyses compared to the visual neuro-radiological evaluation. 2020.

[button]Download[/button]

  • Topic: Published research

Insights

Cortechs.ai | Cortechs.ai and EDAP Announce World’s First OnQ™ Prostate-Assisted Focal One® Robotic HIFU Procedure at UCSF Prostate Cancer Center
  • 3 mins

02/06/2025

Cortechs.ai and EDAP Announce World’s First OnQ™ Prostate-Assisted Focal One® Robotic HIFU Procedure at UCSF Prostate Cancer Center

This milestone marks the first clinical use of OnQ Prostate’s RSI technology to guide focal therapy, improving lesion localization and targeting for urologists.

Cortechs.ai | LesionQuant for assessment of MRI in MS
  • 3 mins

02/02/2025

NeuroQuant® Brain Tumor: Revolutionizing Neuro-Oncology with AI-Driven Precision

Dr. Suzie Bash and Dr. Jeff Rudie dive deep into the advanced functionalities and clinical benefits of the tool that is revolutionizing neuro-oncology

Cortechs.ai | Revolutionizing Imaging Diagnostics with Cortechs.ai CEO, Kyle Frye
  • < 1 mins

01/28/2025

Revolutionizing Imaging Diagnostics with Cortechs.ai CEO, Kyle Frye

Hear from CEO Kyle Frye on the SCALE Community Podcast about how Cortechs.ai is transforming healthcare with cutting-edge AI-powered medical imaging solutions.

,

View our insights
Cortechs.ai | LesionQuant for assessment of MRI in MS
Cortechs.ai | LesionQuant for assessment of MRI in MS

Empowering precision

and clarity in patient care

5060 Shoreham Place,
Ste 240, San Diego, CA 92122

  • Solutions
  • © Cortechs.ai 2024
Scroll to Top